Details |
Aging Populations |
Biology
of Aging
Steven Castle, University of California at Los Angeles,
Los Angeles, CA
Biology
of Immune Senescence
Richard Miller, University of Michigan, Ann Arbor,
MI
HIV
in the Older Patient
Bradley Bender, University of Florida, Gainesville,
FL
Impact
of Aging on the Epidemiology of Infections in Adults
Thomas Yoshikawa, Charles R. Drew University of Medicine
and Science, Los Angeles, CA
|
Antimicrobial
Resistance |
The
Acquisition of Ciprofloxacin Resistance in Travel-Associated
and Home-Acquired Campylobacter jejuni Infection:
A Case-case Comparison
Iain Gillespie, Public Health Laboratory Service, London,
United Kingdom
Antibiotic
Susceptibility and the Mechanisms of Macrolide Resistance
in Invasive Group B Streptococcus, Minnesota, 1998
and 2000
Joanne Bartkus, Minnesota Department of Health, Minneapolis,
MN
Antimicrobial
Resistance in Salmonella is Associated with Increased Hospitalization: NARMS 1996-2000
J.K. Varma, CDC, Atlanta, GA
Antimicrobial
Resistance in Salmonella Serotype Typhimurium, R-Type ACSSuT,
is Associated with Bacteremia: NARMS 1996-2000
Kare Molbak, Statens Serum Institut, Copenhagen, Denmark
Computerized
Decision Support for Appropriate Antimicrobial Drug Prescribing
Matthew Samore, University of Utah, Salt Lake City,
UT
Controlling
Antimicrobial Resistance
Barry Farr, University of Virginia Hospital, Charlottesville,
VA
Emerging
Fluoroquinolone Resistance among Non-Typhoidal Salmonella
in the United States: NARMS 1996-2000
Shannon Rossiter, CDC, Atlanta, GA
Global
Drug Resistance: The Case of Streptococcus pneumoniae
Keith Klugman, School of Public Health, Emory University,
Atlanta, GA
High
Prevalence of Antibiotic Resistance in Enterotoxigenic
E. coli (ETEC); Minnesota 2000-2001
John Besser, Minnesota Department of Health, Minneapolis,
MN
Implications
of Gene Transfer and Inducible Resistance for Successful Therapy
Abigail Salyers, American Society for Microbiology,
Washington, DC
Multi-Drug
Resistant Neisseria gonorrhoeae with Decreased Susceptibility
to Cefixime, Hawaii, 2001
Susan Wang, CDC, Atlanta, GA
Prevalence
and Consequences of Fluoroquinolone-Resistant Campylobacter
Infections: NARMS 1997-2000
Jennifer McClellan, CDC, Atlanta, GA
Prevalence
of Salmonella spp. and Campylobacter spp.
Following the Discontinued Use of Antimicrobial Growth Promoters
in Broilers and Swine in Denmark
Mary Evans, Danish Veterinary Institute, Copenhagen,
Denmark
Promoting
Appropriate Antimicrobial Drug Use in Developing Countries
Sayomporn Sirinavin, Mahidol University, Bangkok, Thailand
Prospects
for New Antimicrobial Drug Development: Industry Perspective
Gail Cassell, Eli Lilly and Company, Indianapolis,
IN
Quinupristin/Dalfopristin-Resistant
Enterococcus faecium Isolated from Human Stools,
Retail Chicken, and Retail Pork: EIP Enterococci Project
Kathryn Gay, CDC, Atlanta, GA
Randomized
Trial of Day Care Staff Education to Improve Parent Knowledge
and Attitudes Regarding Appropriate Antibiotic Use
Donita Croft, Wisconsin Division of Public Health and
CDC, Madison, WI
Real-time
International Surveillance of Antimicrobial Resistance by
the Enter-net Surveillance Network
Ian Fisher, PHLS Communicable Disease Surveillance
Centre, London, United Kingdom
Shigella
dysenteriae Serotype 1 in West Africa: Intervention Strategy
for an Outbreak in Sierra Leone, 1999-2000
Philippe Guerin, Epicentre, Paris, France
|
Behavioral
Change |
Bringing
Dengue Prevention Down to Earth: Evaluation of a Head Start
Project in Puerto Rico
Carmen Pérez-Guerra, CDC, San Juan, PR
The
Essential Role of Behavioral and Social Sciences in the Prevention
of Emerging Infectious Diseases
Emily Zielinski-Gutiérrez, CDC, Fort Collins, CO
Increasing
Water Vessel Use in Kenya
Philip Makutsa, CARE International in Kenya, Homa Bay,
Kenya
Randomized
Trial of Day Care Staff Education to Improve Parent Knowledge
and Attitudes Regarding Appropriate Antibiotic Use
Donita Croft, Wisconsin Division of Public Health and
CDC, Madison, WI
Sex
Workers as Targets of and Agents for HIV/STI Prevention
Rafael Mazin, Pan American Health Organization HCA/HCP,
Washington, DC
|
Bioterrorism
|
Anthrax in the U.S. Postal System
Michele Pearson, CDC, Atlanta, GA
An
Anthrax Outbreak Averted: Public Health Response to a Contaminated
Envelope on Capitol Hill, Washington, DC, 2001
V.P. Hsu, CDC, Atlanta, GA
Anthrax
Vaccines
Arthur Friedlander, U.S. Army Medical Research Institute
of Infectious Diseases, Fort Detrick, MD
Bioterrorism
Richard Hoffman, University of Colorado Health Sciences
Center, Denver, CO
Bioterrorism
2001: Lessons Learned
L.A. Cole, Rutgers University, Newark, NJ
Bioterrorism
Preparedness: Lessons, Challenges, and Opportunities
James Hughes, Director, National Center for Infectious
Diseases, CDC, Atlanta, GA
BT
Surveillance in NYC
Farzad Mostashari, Bureau of Communicable Disease,
New York City Department of Health, New York, NY
Clinical
and Epidemiologic Features of Smallpox
Stanley Foster, Rollins School of Public Health, Emory
University, Atlanta, GA
Clinical
Management of Smallpox Patients
Peter L. Havens, Medical College of Wisconsin, Milwaukee,
WI
Cutaneous Anthrax in New York City
Marcelle Layton, New York Department of Health, New
York, NY
Enhanced
Emergency Department Surveillance System Following the World
Trade Disaster – New York City, September 14 to October 10,
2001
Debjani Das, New York Department of Health, New York,
NY
Importance
of Bacillus anthracis Molecular Subtyping During the
Recent Multi-State Bioterrorism-Associated Anthrax Outbreak
in the United States
A. Hoffmaster, CDC, Atlanta, GA
Inhalation Anthrax in Florida
Steve Wiersma, Florida Department of Health, Tallahassee,
FL
Inhalation Anthrax of Unknown Source
James Hadler, Connecticut Department of Public Health,
Hartford, CT
Inhalational
AnthraxNew York City, October-November 2001
T.H. Holtz, New York City Department of Health, New
York, NY
Laboratory
Response in the Commonwealth of Virginia to the Intentional
Release of Bacillus anthracis
Denise Pettit, Division of Consolidated Laboratory
Services, Richmond, VA
Letters from
Trenton: The Anthrax Investigation at the Source, New Jersey,
2001
J. Reefhuis, CDC, Atlanta, GA
Public
Health Laboratory Response to an Anthrax Incident in Connecticut
Donald Mayo, Connecticut State Health Department, Hartford,
CT
Rapid
Adaptation of a Serologic Assay for the Bioterrorism-Related
Anthrax OutbreakOctober-December, 2001
C.M. Greene, CDC, Atlanta, GA
Rapid
Molecular Identification of B. anthracis in New York
State in Response to Recent Bioterrorism Incidents
Kimberlee Musser, New York, State Department of Health,
Albany, NY
The Role of Healthcare
Systems in Bioterrorism Preparedness
Trish Perl, Johns Hopkins Hospital, Baltimore, MD
Smallpox
Vaccine and Vaccination Strategies
Joanne Cono, CDC, Atlanta, GA
Surveillance
of Livestock for Zoonotic Diseases and Veterinary Bio-Threat
Agents
William Hueston, College of Veterinary Medicine, University
of Minnesota, St. Paul, MN
Threat
Letter Menace: The Fiji Experience
Kamal Kishore, Fiji School of Medicine, Suva, Fiji
|
Chronic
Diseases |
Failure
To Detect C. pneumoniae in Atherosclerotic Specimens
Silvio Pitlik, Rabin Medical Center, Petah Tikvah, Israel
Intestinal
Anaerobic Bacteria in Early Rheumatoid Arthritis
Paavo Toivanen, Turku University, Turku, Finland
Outbreak
of Cryptococcus neoformans var. gattii in a Restricted Zone in British Columbia
Mike Starr, University of British Columbia Centre
for Disease Control, Vancouver, BC, Canada
Postdiarrheal
Hemolytic Uremic Syndrome in New York State
H.H. Chang, New York State Department of Health, Albany,
NY
Prevalence
of Hepatitis C and other Chronic Liver Disease Etiologies
in Primary Care Practices
Andre Sofair, Connecticut Emerging Infections Program,
New Haven, CT
Tuberculosis
Gene Deletion Typing, Not YATM ("Yet Another Typing Method")
Yves Goguet, Stanford University, Stanford, CA
|
Disease
Eradication |
Eradication
of Chagas Disease
Gabriel Schmunis, Pan American Health Organization,
Washington, DC
Eradication
of Dracunculiasis
Ernesto Ruiz-Tiben, CDC, Atlanta, GA
Eradication
of Lymphatic Filariasis and Onchocerciasis
Eric Ottesen, Lymphatic Filariasis Support Center,
Rollins School of Public Health, Emory University, Atlanta,
GA
Eradication
of T. solium Cysticercosis
Peter Schantz, CDC, Atlanta, GA
Overview:
Disease Eradication
Walter Dowdle, Task Force for Child Survival and Developement,
Atlanta, GA
|
Foodborne/Waterborne
Illnesses |
Antimicrobial
Resistance in Salmonella is Associated with Increased Hospitalization: NARMS 1996-2000
J.K. Varma, CDC, Atlanta, GA
Antimicrobial
Resistance in Salmonella Serotype Typhimurium, R-Type ACSSuT,
is Associated with Bacteremia: NARMS 1996-2000
Kare Molbak, Statens Serum Institut, Copenhagen, Denmark
Campylobacter coliWhats the Big Deal?
Sarah O'Brien, Public Health Laboratory Service, London,
United Kingdom
Challenges
in the Interpretation of Classical and Molecular Epidemiology
Results; Two Calicivirus Outbreaks Due to Oysters, Denmark at New Year 2000
Francois-Xavier Hanon, Statens Serum Institut, Copenhagen,
Denmark
Changing
Epidemiological Patterns of Salmonella serotype Enteritidis
in Barbados: Implications for Tourism and Trade
Lisa Indar-Harrinauth, University of the West Indies, St. Augustine,
Trinidad and Tobago
Coordinating
Environmental Public Health Practice with Epidemiology and
Laboratory Analysis: A Waterborne Outbreak of "Norwalk-like
Virus" in the Big Horn Mountains of Wyoming
Scott Seys, Wyoming Department of Health, Cheyenne,
WY
Development
and Evaluation of PCR-Based Diagnostics for Identification
of Salmonella O Antigens Based on the rfb Locus
Collette Fitzgerald, CDC, Atlanta, GA
Emerging
Fluoroquinolone Resistance among Non-Typhoidal Salmonella
in the United States: NARMS 1996-2000
Shannon Rossiter, CDC, Atlanta, GA
Enhanced
Laboratory-Based Surveillance of Shiga Toxin-producing
Escherichia coli O157, the Netherlands
Yvonne Van Duynhoven, National Institute of Public
Health and the Environment, Bilthoven, The Netherlands
Epidemiology of Shiga
Toxin-Producing Escherichia coli (STEC) Infections
in Connecticut, February 1, 2000-January 31, 2001
Q. Phan, Connecticut Department of Public Health, Hartford,
CT
Eradication
of Lymphatic Filariasis and Onchocerciasis
Eric Ottesen, Lymphatic Filariasis Support Center,
Rollins School of Public Health, Emory University, Atlanta,
GA
Eradication
of T. solium Cysticercosis
Peter Schantz, CDC, Atlanta, GA
Evidence
of Effectiveness of Egg Quality Assurance Programs, Mandatory
Refrigeration, and Traceback Investigations to Mitigate Egg-Associated
Salmonella enteritidis Infections in the United States
Gerald Mumma, CDC, Atlanta, GA
Foodborne
Disease
Leslie
Kux, U.S. Food and Drug Administration, Rockville, MD
Foodborne
Viruses in Europe: Web-Based Technologies for Investigation
of Transnational Outbreaks of Viral Gastroenteritis
Ben Lopman, Public Health Laboratory Service, London,
United Kingdom
Food
Safety: Perceived Risk and Public Trust
Carol Tucker Foreman, Consumer Federation of America,
Washington, DC
The Globalization
of Our Food Supply: Implications for Emerging Infections
Michael Osterholm, University of Minnesota Academic
Health Center, Minneapolis, MN
Health
Impact of the Salmonella enterica serotype Enteritidis Phage Type 4 Epidemic
Goutam Adak, Public Health Laboratory Service, London,
United Kingdom
High
Prevalence of Antibiotic Resistance in Enterotoxigenic
E. coli (ETEC); Minnesota 2000-2001
John Besser, Minnesota Department of Health, Minneapolis,
MN
Incidence
and Type Distribution of Astrovirus Among Spanish Children
Alicia Sánchez-Fauquier, Centro Nacional de Microbiología,
Madrid, Spain
Increasing
Water Vessel Use in Kenya
Philip Makutsa, CARE International in Kenya, Homa Bay,
Kenya
Integrated Surveillance
and Control of Emerging Foodborne Diseases—The Successful
Danish Experience
Henrik Wegener, Danish Zoonosis Institute, Denmark
Is
Drinking Water a Risk Factor for Endemic Cryptosporidiosis
in the Immunocompetent General Population of the San Francisco
Bay Area?
Asheena Khalakdina, University of California at Berkeley,
Berkeley, CA
Microbiologic
Testing to Identify Shiga Toxin-Producing E. coli in
HUS Patients: FoodNet 1997-2001
C.R. Braden, CDC, Atlanta, GA
A
Molecular Approach to the Epidemiology of Giardia duodenalis
in a Peruvian Shantytown
Paul Hoover, University of Arizona, Tucson, AZ
Molecular
Characterization of a Multiresistant Strain of Salmonella
enterica serotype Typhimurium DT204b Responsible for an
International Outbreak of Salmonellosis
E.J. Threlfall, Central Public Health Laboratory, London,
United Kingdom
Multi-State
Outbreak of Salmonella Senftenberg Infections Associated
with Green GrapesWestern States, 2001
A.B. Cronquist, CDC, Denver,
CO
An
Outbreak of Salmonella Javiana Associated with Amphibian
ContactMississippi, 2001
Padmini Srikantiah, CDC, Atlanta, GA
Outbreak
of Viral Gastroenteritis and an Ill Baker Who Should Have
Known Better: Novel Application of E-mail for Rapid Investigation
Marc-Alain Widdowson, CDC, Atlanta, GA
Outbreaks
of Multidrug-Resistant Salmonella Serotype Typhimurium
Infections Associated with Small Animal Veterinary Facilities
in Idaho, Minnesota, and Washington, 1999
Jennifer Wright, CDC, Atlanta, GA
Prevalence
and Consequences of Fluoroquinolone-Resistant Campylobacter
Infections: NARMS 1997-2000
Jennifer McClellan, CDC, Atlanta, GA
Public
Health and Policy Implications of the Recent Large Drinking
Water Outbreaks in Canada
Andrea Ellis, Center for Infectious Diseases Prevention
and Control, Guelph, Ontario, Canada
PulseNet
and Beyond
Balasubra Swaminathan, CDC, Atlanta, GA
PulseNet Experience:
Software Changes and Improvements to Online E. coli National
Database
Susan Hunter, CDC, Atlanta, GA
Prevalence
of Salmonella spp. and Campylobacter spp.
Following the Discontinued Use of Antimicrobial Growth Promoters
in Broilers and Swine in Denmark
Mary Evans, Danish Veterinary Institute, Copenhagen,
Denmark
Quinupristin/Dalfopristin-Resistant
Enterococcus faecium Isolated from Human Stools,
Retail Chicken, and Retail Pork: EIP Enterococci Project
Kathryn Gay, CDC, Atlanta, GA
Real-time Fluorescence
PCR Assays for the Detection and Characterization of Heat-Labile
and Heat-Stable Enterotoxin Genes from Enterotoxigenic Escherichia
coli
Nancy Strockbine, CDC, Atlanta, GA
Re-estimating
the Global Burden of Typhoid Fever
John Crump, CDC, Atlanta, GA
Risk
Factors for Sporadic Escherichia coli O157 Infections
in the United States: A Case-Control Study in FoodNet Sites,
1999-2000
M.H. Kennedy, CDC, Atlanta, GA
The
Risk of Food and Water Contamination from Animal Manure
Christine Moe, Rollins School of Public Health, Emory
University, Atlanta, GA
Sesame-Seed Paste Caused an International Outbreak Due to Salmonella
Typhimurium DT104The Investigation in Norway
Ole Alvseike, Norwegian Institute of Public Health,
Oslo, Norway
Three
Outbreaks of E. coli O157 Infections Due to Retail
Ground Beef in Minnesota, 2000: Detection, Investigation,
and Characteristics
Ellen Swanson, Minnesota Department of Health, Minneapolis,
MN
Washington Clinical
Laboratory InitiativeAssessment of Laboratory Practice
Jon Counts, University of Washington, Seattle, WA
A WHO Global
Salm-Surv Retrospective Study Examining Salmonella Serotypes
in South America, 2000: Dominance of Salmonella Serotype
Enteritidis
WHO Global Salm-Surv South America Working Group, Instituto
INEI-ANLIS "Carlos G. Malbran", Buenos Aires, Argentina
Yersinia
enterocolitica Surveillance
in Minnesota
Joni Scheftel, Minnesota Department of Health, Minneapolis,
MN
|
Global
Health |
Bioterrorism
Richard Hoffman, University of Colorado Health Sciences
Center, Denver, CO
CDC-PAHO
Collaboration: Surveillance of Emerging/Reemerging Diseases
in the Amazon and the Southern Cone Region
Gabriel Schmunis, Pan American Health Organization,
Washington, DC
Emerging
Infectious Diseases: The World Bank Perspective
O.K. Pannenborg, The World Bank, Washington, DC
Emerging
Vectorborne Disease: The Case of Yellow Fever
C.J. Peters, University of Texas, Medical Branch, Galveston,
TX
Foodborne
Disease
Leslie
Kux, U.S. Food and Drug Administration, Rockville, MD
Genetic
Susceptibility to Infectious Diseases
Janet McNicholl, CDC, Atlanta, GA
Global Fund to Fight HIV/AIDS, TB, and Malaria (New Political/Economic
Model for Addressing Priority Infectious Diseases)
Bill Steiger, U.S. Department of Health and Human Services,
Washington DC
Global Health, Emerging Infectious Diseases, and International Regulations
David Fidler, School of Law, Indiana University, Bloomington,
IN
The
Globalization of Our Food Supply: Implications for Emerging
Infections
Michael Osterholm, University of Minnesota Academic
Health Center, Minneapolis, MN
Global
Migration and Emerging Infectious Diseases
Daniele Grondin, International Organization for Migration, Geneva, Switzerland
Investigation
of Q Fever in Bosnia-Herzegovina, 2000: An Example of International
Cooperation
Jennifer McQuiston, CDC, Atlanta, GA
Laboratory Capacity
Brad Kay, WHO, Lyon, France
Ray Arthur, WHO, Geneva, Switzerland
Mapping of West
Nile Virus Risk in the Northeast United States Using Multi-Temporal Meteorological Satellite Data
P. Bryon Backenson, New York State Department of Health,
Albany, NY
Protecting
the Nation's Health in an Era of Globalization: CDC's Global
Infectious Disease Strategy
Scott Dowell, CDC, Atlanta, GA
Update
on the WHO Global Alert and Response Network
Ray Arthur, WHO, Geneva, Switzerland
West
Nile Virus in New York City
Wilfredo Lopez, New York City Department of Health,
New York, NY
A WHO Global
Salm-Surv Retrospective Study Examining Salmonella Serotypes
in South America, 2000: Dominance of Salmonella Serotype
Enteritidis
WHO Global Salm-Surv South America Working Group, Instituto
INEI-ANLIS "Carlos G. Malbran", Buenos Aires, Argentina
The World
and Its Moving Parts: An Overview (from world and moving
parts???)
Martin Cetron, CDC, Atlanta, GA
|
Healthcare
Setting |
Antimicrobial
Resistance in Salmonella is Associated with Increased Hospitalization: NARMS 1996-2000
J.K. Varma, CDC, Atlanta, GA
Controlling Antimicrobial
Resistance
Barry Farr, University of Virginia Hospital, Charlottesville,
VA
Increasing Detection
of Malaria in U.S. Hospitals Using the OptiMAL Rapid Diagnostic
Test
Carol Palmer, University of Florida, Gainesville, FL
Patient Safety:
Applying Industrial Quality Models in Healthcare Settings
to Improve Outcomes
Julie Gerberding, CDC, Atlanta, GA
Prevention of Intravascular Catheter-Related Infections
Leonard Mermel, Rhode Island Hospital, Providence,
RI
The Role of Healthcare
Systems in Bioterrorism Preparedness
Trish Perl, Johns Hopkins Hospital, Baltimore, MD
|
Influenza |
Acute Respiratory
Virus Surveillance in Cairo and Alexandria, Egypt, July 2000-June
2001
Diaa Salman, U.S. Naval Medical Research Unit No 3.,
Cairo, Egypt
Analysis
of a Health Indicator Surveillance System: Its Ability to
Detect Annual Influenza Activity for the 1999-2000 and 2000-2001
Seasons Compared to Traditional Surveillance Systems
Ji-Eun Lee, Department of Defense Global Emerging Infections
System, Silver Spring, MD
A
DoD Global Influenza Surveillance Program
Linda Canas, Brooks Air Force Base, San Antonio, TX
Geographical
Coherence of Influenza Epidemics in the U.S., France, and
Australia: 1978-1998
Cecile Viboud, INSERM U444, Paris cedex 12, France
Improving
Influenza and Pneumococcal Vaccination Rates for People 65+
in Rhode Island through Coalition Building Efforts
Thomas Bertrand, Rhode Island Department of Health,
Providence, RI
Influenza Surveillance
in New York State, 1998-2001
Marilyn Kacica, New York State Department of Health,
Albany, NY
PER.C6: A Human
Designer Cell Line Providing a Pandemic-Proof Platform for
the Manufacturing of Safe Influenza Vaccines
Fons UytdeHaag, Crucell Holland BV, Leiden, The Netherlands
Shared
Animal and Human Influenza Viruses: A Role in the Next Pandemic?
Kennedy Shortridge, University of Hong Kong, Queen Mary Hospital,
Hong Kong
Using CUSUM Techniques
to Identify Influenza Outbreaks
Michael Stoto, The Rand Corporation, Arlington, VA
Virology
of 1918 Flu Pandemic
Ann Reid, Armed Forces Institute of Pathology, Washington,
DC
|
Molecular
Diagnostics and Epidemiology |
Challenges
in the Interpretation of Classical and Molecular Epidemiology
Results; Two Calicivirus Outbreaks Due to Oysters, Denmark at New Year 2000
Francois-Xavier Hanon, Statens Serum Institut, Copenhagen,
Denmark
Changes
in Circulating Enterovirus Serotypes in the United States,
2001
Andy Mullins, CDC, Atlanta, GA
Detection
and Typing of Enterovirus in Cerebrospinal Fluid
Blair Rosen, New York State Department of Health, Slingerlands,
NY
Detection of
La Crosse Virus in Cerebrospinal Fluid and Tissues by Reverse
Transcription-Polymerase Chain Reaction
Brett Slater, New York State Department of Health,
Slingerlands, NY
Determination
of Allelic Diversity in the mec Operon of Methicillin-Resistant
Staphylococcus aureus in Wisconsin
Sanjay Shukla, Marshfield Medical Research Foundation,
Marshfield, WI
Development and
Evaluation of PCR-Based Diagnostics for Identification of
Salmonella O Antigens Based on the rfb Locus
Collette Fitzgerald, CDC, Atlanta, GA
Importance of
Bacillus anthracis Molecular Subtyping During the Recent
Multi-State Bioterrorism-Associated Anthrax Outbreak in the
United States
A. Hoffmaster, CDC, Atlanta, GA
Incidence and
Type Distribution of Astrovirus Among Spanish Children
Alicia Sánchez-Fauquier, Centro Nacional de Microbiología,
Madrid, Spain
Increasing Detection
of Malaria in U.S. Hospitals Using the OptiMAL Rapid Diagnostic
Test
Carol Palmer, University of Florida, Gainesville, FL
Microbiologic
Testing to Identify Shiga Toxin-Producing E. coli in
HUS Patients: FoodNet 1997-2001
C.R. Braden, CDC, Atlanta, GA
A Molecular Approach
to the Epidemiology of Giardia duodenalis in a Peruvian
Shantytown
Paul Hoover, University of Arizona, Tucson, AZ
Molecular Characterization
of a Multiresistant Strain of Salmonella enterica serotype
Typhimurium DT204b Responsible for an International Outbreak
of Salmonellosis
E.J. Threlfall, Central Public Health Laboratory, London,
United Kingdom
PulseNet Experience:
Software Changes and Improvements to Online E. coli National
Database
Susan Hunter, CDC, Atlanta, GA
Rapid
Adaptation of a Serologic Assay for the Bioterrorism-Related
Anthrax OutbreakOctober-December, 2001
C.M. Greene, CDC, Atlanta, GA
Rapid
Screening and Identification of West Nile Virus in Captive
and Wild Birds Using Non-Invasive Environmental Samples and
a Portable TaqMan RT-PCR
Johnny Callahan, Tetracore, Inc., Gaithersburg, MD
Real-time
Fluorescence PCR Assays for the Detection and Characterization
of Heat-Labile and Heat-Stable Enterotoxin Genes from Enterotoxigenic
Escherichia coli
Nancy Strockbine, CDC, Atlanta, GA
|
Pathogen
Discovery |
Clusters
of Clinical Syndromes in Patients with Unexplained Encephalitis
Carol Glaser, California Department of Health Services,
Berkeley, CA
First
Encounters with New Diseases: The Clinician's Perspective
Merle Sande, University of Utah, Salt Lake City, UT
Multiple
Array Technology to Look for mRNA Patterns Associated with
Disease and Pathogens
David Relman, Stanford University, Stanford, CA
The New
Human Metapneumovirus
Albert Osterhaus, University of Rotterdam, Rotterdam,
The Netherlands
Proteomics
and Pathogen Discovery
Donald Hunt, University of Virginia, Charlottesville,
VA
|
Prevention
and Control Strategies |
Active Laboratory
Surveillance in Massachusetts
Bela Matyas, Massachusetts Department of Public Health,
Jamaica Plain, MA
The Emergence
of Serogroup Y Disease and the Epidemiology of Invasive Meningococcal
Disease in Colorado, 1997-2001
Lucinda Hammond, Colorado Department of Public Health
and Environment, Denver, CO
An Evaluation
of an Educational Videotape to Prevent Botulism among Alaska
Natives
Catherine Dentinger, CDC, Anchorage, AK
Evidence of
Effectiveness of Egg Quality Assurance Programs, Mandatory
Refrigeration, and Traceback Investigations to Mitigate Egg-Associated
Salmonella enteritidis Infections in the United States
Gerald Mumma, CDC, Atlanta, GA
Genetic
Susceptibility to Infectious Diseases
Janet McNicholl, CDC, Atlanta, GA
Improving
Influenza and Pneumococcal Vaccination Rates for People 65+
in Rhode Island through Coalition Building Efforts
Thomas Bertrand, Rhode Island Department of Health,
Providence, RI
New Strategies on
the Old Ideas: Malaria Control Without Insecticides and Community
Participation in Aedes aegypti Control, Mexico's Experiences
Jorge F. Méndez-Galván, Ministry of Health, Mexico
City, Mexico
Prevention
Effectiveness
Martin Meltzer, CDC, Atlanta, GA;
Anne Haddix, School of Public Health, Emory University,
Atlanta, GA
Transmission
of the Main Viral Pathogens Causing Gastroenteritis, NLV,
SLV, and Rotavirus
Yvonne van Duynhoven, National
Institute of Public Health and the Environment, Bilthoven,
The Netherlands
|
Public
Health Policy and Law |
Bioterrorism
Richard Hoffman, University of Colorado Health Sciences
Center, Denver, CO
Foodborne
Disease
Leslie
Kux, U.S. Food and Drug Administration, Rockville, MD
Global Health, Emerging Infectious Diseases, and International Regulations
David Fidler, School of Law, Indiana University, Bloomington,
IN
West
Nile Virus in New York City
Wilfredo Lopez, New York City Department of Health,
New York, NY
|
Surveillance
Systems |
Active Laboratory
Surveillance in Massachusetts
Bela Matyas, Massachusetts Department of Public Health,
Jamaica Plain, MA
Acute Respiratory
Virus Surveillance in Cairo and Alexandria, Egypt, July 2000-June
2001
Diaa Salman, U.S. Naval Medical Research Unit No 3.,
Cairo, Egypt
Analysis
of a Health Indicator Surveillance System: Its Ability to
Detect Annual Influenza Activity for the 1999-2000 and 2000-2001
Seasons Compared to Traditional Surveillance Systems
Ji-Eun Lee, Department of Defense Global Emerging Infections
System, Silver Spring, MD
BT Surveillance
in NYC
Farzad Mostashari, Bureau of Communicable Disease,
New York City Department of Health, New York, NY
CDC-PAHO
Collaboration: Surveillance of Emerging/Reemerging Diseases
in the Amazon and the Southern Cone Region
Gabriel Schmunis, Pan American Health Organization, Washington,
DC
CD
Electronic Surveillance in the UK and EU
Michael Catchpole, PHLS Communicable Disease Surveillance
Centre, London, United Kingdom
A
DoD Global Influenza Surveillance Program
Linda Canas, Brooks Air Force Base, San Antonio, TX
Enhanced
Emergency Department Surveillance System Following the World
Trade Disaster – New York City, September 14 to October 10,
2001
Debjani Das, New York Department of Health, New York,
NY
Enhanced
Laboratory-Based Surveillance of Shiga Toxin-producing
Escherichia coli O157, the Netherlands
Yvonne Van Duynhoven, National Institute of Public
Health and the Environment, Bilthoven, The Netherlands
Foodborne
Viruses in Europe: Web-Based Technologies for Investigation
of Transnational Outbreaks of Viral Gastroenteritis
Ben Lopman, Public Health Laboratory Service, London,
United Kingdom
Influenza
Surveillance in New York State, 1998-2001
Marilyn Kacica, New York State Department of Health,
Albany, NY
Integrated
Surveillance and Control of Emerging Foodborne Diseases—The
Successful Danish Experience
Henrik Wegener, Danish Zoonosis Institute, Denmark
Lessons
Learned from Implementing Electronic Laboratory Reporting,
New York State
Perry Smith, New York State Department of Health, Albany,
NY
Lyme
Disease Incidence in Wisconsin: A Comparison of State Reported
Rates with Rates from a Population-Based Cohort
Allison Naleway, Marshfield Medical Research Foundation,
Marshfield, WI
Outbreak
Surveillance: An Important Tool for Controlling Communicable
Diseases
Michael Baker, ESR, Wellington, New Zealand
PulseNet and
Beyond
Balasubra Swaminathan, CDC, Atlanta, GA
PulseNet Experience:
Software Changes and Improvements to Online E. coli National
Database
Susan Hunter, CDC, Atlanta, GA
Real-time International
Surveillance of Antimicrobial Resistance by the Enter-net
Surveillance Network
Ian Fisher, PHLS Communicable Disease Surveillance Centre,
London, United Kingdom
Surveillance
for Patients with Acute Febrile Illness in Egypt
Salma Afifi, U.S. Naval Medical Research Unit No. 3,
Cairo, Egypt
Surveillance
of Livestock for Zoonotic Diseases and Veterinary Bio-Threat
Agents
William Hueston, College of Veterinary Medicine, University
of Minnesota, St. Paul, MN
Yersinia
enterocolitica Surveillance
in Minnesota
Joni Scheftel, Minnesota Department of Health, Minneapolis,
MN
|
Vaccines |
Anthrax
Vaccines
Arthur Friedlander, U.S. Army Medical Research Institute
of Infectious Diseases, Fort Detrick,
MD
Group
B Meningococcal Vaccines
Gustavo Sierra, Finlay Institute, Havana, Cuba
Improving
Influenza and Pneumococcal Vaccination Rates for People 65+
in Rhode Island through Coalition Building Efforts
Thomas Bertrand, Rhode Island Department of Health,
Providence, RI
New
Technologies and Vaccine Development
Margaret Ann Liu, Bill and Melinda Gates Foundation,
Seattle, WA
Rotavirus
Vaccines in Development
Rajiv Bahn, All India Institute of Medical Sciences,
New Delhi, India
Smallpox
Vaccine and Vaccination Strategies
Joanne Cono, CDC, Atlanta, GA
Virology
and Diagnosis of Smallpox
Russell Regnery,
CDC, Atlanta, GA
|
Vectorborne
Diseases |
Dengue
Fever Outbreak in Hawaii2001
Paul Effler, State of Hawaii Department of Health,
Honolulu, HI
Ecological
Niche Modeling and Differentiation of Populations of Triatoma
Brasiliensis Neiva, 1911, the Most Important Chagas Disease
Vector in Northeastern Brazil (Hemiptera, Reduviidae, Triatominae)
Jane Costa, CDC, Atlanta, GA
The
Emergence of Rift Valley Fever in the Arabian Peninsula, 2000
Hammam El Sakka, U.S. Naval Medical Research Unit No
3, Cairo, Egypt
Emerging
Vectorborne Infections
Barry Beatty, Colorado State University, Fort Collins,
CO
Duane Gubler, CDC, Fort Collins, CO
Emerging
Vectorborne Disease: The Case of Yellow Fever
C.J. Peters, University of Texas, Medical Branch, Galveston,
TX
Eradication
of Chagas Disease
Gabriel Schmunis, Pan American Health Organization,
Washington, DC
A Greenhouse
Study to Model Potential Field Use of Genetically Modified
Bacterial Symbionts for Chagas' Disease Control
Pritha Sen, CDC, Atlanta, GA
Increasing Detection
of Malaria in U.S. Hospitals Using the OptiMAL Rapid Diagnostic
Test
Carol Palmer, University of Florida, Gainesville, FL
In vivo Sensitivity
of Plasmodium falciparum to Chloroquine and Sulfadoxine/Pyrimethamine
During an Outbreak of Malaria in Burundi, 2001
François Dantoine, Epicentre, Paris, France
Mapping of West
Nile Virus Risk in the Northeast United States Using Multi-Temporal Meteorological Satellite Data
P. Bryon Backenson, New York State Department of Health,
Albany, NY
Microheterogenicity
of the Volgograd Clone of West Nile Virus
Alexander Platonov, Central Research Institute of Epidemiology,
Moscow, Russian Federation
A
Molecular Approach to the Epidemiology of Giardia duodenalis
in a Peruvian Shantytown
Paul Hoover, University of Arizona, Tucson, AZ
Monitoring
of Human Exposure to Bacillus thuringiensis After
Aerial Applications for Insect Control
David Levin, University of Victoria, Victoria, BC,
Canada
New
Strategies on the Old Ideas: Malaria Control Without Insecticides
and Community Participation in Aedes aegypti Control,
Mexico's Experiences
Jorge F. Méndez-Galván, Ministry of Health, Mexico
City, Mexico
Rapid
Screening and Identification of West Nile Virus in Captive
and Wild Birds Using Non-Invasive Environmental Samples and
a Portable TaqMan RT-PCR
Johnny Callahan, Tetracore, Inc., Gaithersburg, MD
Re-introduction
of Dengue 3 in Aragua, Venezuela: Clinical, Epidemiological
and Laboratory Features of a New Outbreak
Guillermo Comach, Lardidev-Biomed, Universidad de Carabobo,
Maracay, Venezuela
Risk Factors
for Lyme Borreliosis: A German Case-Control Study
Andrea Ammon, Robert Koch Institute, Berlin, Germany
Trypanosomiasis as
a Reemerging Infection
Anne Moore, CDC, Atlanta, GA
West Nile Virus
First Transmission Season in Florida, 2001More Than
400 Horse Cases and 170 Chicken Seroconversions but Only Sporadic
Human Disease
Carina Blackmore, Florida Department
of Health, Jacksonville, FL
West Nile
Virus Infection
Deborah Asnis, Brooklyn, NY
West
Nile Virus in New York City
Wilfredo Lopez, New York City Department of Health,
New York, NY
|
Zoonotic
Diseases |
The
Agent: Prions as Emerging Infectious Particles
David Bolton, New York State Institute for Basic Research,
Staten Island, NY
Are
Martha's Vineyard Landscapers at Increased Risk for Tularemia?Massachusetts,
2001
K.A. Feldman, CDC, Fort Collins, CO
Clinical Management
and Outcomes of Lyme Disease in Wisconsin
Daniel O'Leary, CDC, Fort Collins, CO
Detection
and Genetic Analysis of Swine Hepatitis E Virus in Farm Waste
Theresa Cromeans, CDC, Atlanta, GA
Detection
and Typing of Enterovirus in Cerebrospinal Fluid
Blair Rosen, New York State Department of Health, Slingerlands,
NY
Emergence of Canine Visceral Leishmaniasis in Dogs in North America
Zandra Duprey, CDC, Atlanta, GA
The
Emergence of Infectious Diseases Among Wildlife and the Origin
of Human Zoonoses
Peter Daszak, Consortium for Conservation Medicine,
Palisades, NY
Emerging
Rickettsioses of the Thai-Myanmar Border
Philippe Parola, Harvard School of Public Health, Boston,
MA
Emerging
Zoonoses: A Novel Epizootic of Skunks Infected with a Bat
Variant of Rabies
Mira Leslie, Arizona Department of Health Services,
Phoenix, AZ
Enhanced
Laboratory-Based Surveillance of Shiga Toxin-producing
Escherichia coli O157, the Netherlands
Yvonne Van Duynhoven, National Institute of Public
Health and the Environment, Bilthoven, The Netherlands
Epidemiology
of Raccoon and Skunk Rabies in the Eastern United States
Marta Guerra, CDC, Atlanta, GA
Eradication
of Dracunculiasis
Ernesto Ruiz-Tiben, CDC, Atlanta, GA
Foot
and Mouth Disease
Christopher Bostock, Institute of Animal Health, Compton,
United Kingdom
Hantavirus
Pulmonary Syndrome
Bruce Tempest, Gallup, NM
Impact
of the BSE/vCJD Outbreak: U.S. Concerns for TSEs
Ermias Belay, CDC, Atlanta, GA
The
Interface of Animal and Human Health
Corrie Brown, College of Veterinary Medicine, University
of Georgia, Athens, GA
A
Neighborhood Outbreak of Q Fever Linked to a Goat Ranch in
California
Michele Jay, California Department of Health Services,
Sacramento, CA
An
Outbreak of Salmonella Javiana Associated with Amphibian
ContactMississippi, 2001
Padmini Srikantiah, CDC, Atlanta, GA
Outbreaks
of Multidrug-Resistant Salmonella Serotype Typhimurium
Infections Associated with Small Animal Veterinary Facilities
in Idaho, Minnesota, and Washington, 1999
Jennifer Wright, CDC, Atlanta, GA
Outbreaks
of Salmonellosis at Elementary Schools Associated With Dissection
of Owl Pellets
Fred Anderson, Washington County Department of
Public Health and Environment, Stillwater, NM
Preventing
Human Disease by Controlling Pathogen Transmission in the
Animal Reservoir
Charles Rupprecht, CDC, Atlanta, GA
Q
Fever in the United States: Experience of Infectious Disease
Consultants and Comparison to National Reporting During 2000
Jennifer McQuiston, CDC, Atlanta, GA
Recurrent
Histoplasmosis Outbreaks in Acapulco, Mexico
Yuri Roldán-Aragón, National Institute
of Medical Science and Nutrition, Mexico City, Mexico
The
Reservoir: Bovine Spongiform Encephalopathy and What's Been
Done About It
Dagmar Heim, Swiss Federal Veterinary Office, Bern-Liebefeld,
Switzerland
Shared
Animal and Human Influenza Viruses: A Role in the Next Pandemic?
Kennedy Shortridge, University of Hong Kong, Queen Mary Hospital,
Hong Kong
Surveillance
of Livestock for Zoonotic Diseases and Veterinary Bio-Threat
Agents
William Hueston, College of Veterinary Medicine, University
of Minnesota, St. Paul, MN
Trypanosomiasis as
a Reemerging Infection
Anne Moore, CDC, Atlanta, GA
The
Unfolding Variant (vCJD) Epidemic
Robert Will, Western General Hospital, Edinburgh,
United Kingdom
|
|